Definition

This is not a rare disease-causing mutation but a promoter polymorphism common in the population (A allele frequency approximately 0.20%) and considered clinically benign. The A allele mildly raises plasma fibrinogen levels and has been studied in cardiovascular/thrombotic risk research; however it is not on its own predictive of disease. A separate glossary term exists for the actual disease-causing mutations in the FGB gene (Afibrinogenemia/Dysfibrinogenemia/Hypofibrinogenemia).

Gene/region examined

FGB -455G>A

Method

Sequence analysis

Accepted sample types

EDTA blood, AF, CVS

Inheritance

A common polymorphism, not evaluated using a classic disease inheritance model.

Related Tests

Inheritance Patterns

Describes how a genetic condition is passed on within a family. There are five main patterns

Go to term →

Carrier (Heterozygous / Homozygous)

Why it matters: In autosomal recessive inheritance, when each parent is a carrier (while both appear healthy), the chance of their child being born with the disease is 25% in each

Go to term →

VUS (Variant of Uncertain Significance)

This is the situation where the test has detected a change in the DNA, but the role of this change in the development of disease is unconfirmed.

Go to term →

How to Read a Genetic Test Result (Positive / Negative / VUS)

A genetic test result falls into three main categories

Go to term →

Types of Genetic Tests

A genetic test is a type of medical test that detects changes in genes, chromosomes or proteins. Today there are more than 77,000 genetic tests available.

Go to term →